Manchester Molecular Pathology Innovation Centre (MMPathIC)
Manchester Molecular Pathology Innovation Centre (MMPathIC) aims to translate discoveries into tests.
MMPathIC provides an infrastructure that can facilitate the translation of novel markers (from all the 'omics technologies and clinical data), from discovery research, through to implementation of novel pathology tests, biomarker technologies and clinical algorithms to enable the expansion of stratified medicine in the clinic.
Please contact the MMPathIC team for further information.
"MMPathIC has recruited a great team of experts who can help researchers and industry deliver biomarker-based tests to the clinic or market."Professor Tony Freemont / Director, MMPathIC